110 related articles for article (PubMed ID: 15672606)
1. A new set of monoclonal antibodies directed to proline-rich and central regions of p53.
Voeltzel T; Morel AP; Rostan MC; Ji J; Chiodino C; Ponchel F; Vigouroux J; Caron de Fromentel C; Soussi T; Ozturk M
Hybrid Hybridomics; 2004 Oct; 23(5):287-92. PubMed ID: 15672606
[TBL] [Abstract][Full Text] [Related]
2. Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein.
Legros Y; Meyer A; Ory K; Soussi T
Oncogene; 1994 Dec; 9(12):3689-94. PubMed ID: 7526318
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody against DNA binding helix of p53 protein.
Yolcu E; Sayan BS; Yağci T; Cetin-Atalay R; Soussi T; Yurdusev N; Ozturk M
Oncogene; 2001 Mar; 20(11):1398-401. PubMed ID: 11313883
[TBL] [Abstract][Full Text] [Related]
4. The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes.
Wolkowicz R; Elkind NB; Ronen D; Rotter V
Oncogene; 1995 Mar; 10(6):1167-74. PubMed ID: 7535417
[TBL] [Abstract][Full Text] [Related]
5. Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein.
Vojtesek B; Dolezalova H; Lauerova L; Svitakova M; Havlis P; Kovarik J; Midgley CA; Lane DP
Oncogene; 1995 Jan; 10(2):389-93. PubMed ID: 7530828
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody to a multiphosphorylated, conformational epitope at the carboxy-terminus of p53.
Otvos L; Hoffmann R; Xiang ZQ; O I; Deng H; Wysocka M; Pease AM; Rogers ME; Blaszczyk-Thurin M; Ertl HC
Biochim Biophys Acta; 1998 Sep; 1404(3):457-74. PubMed ID: 9739174
[TBL] [Abstract][Full Text] [Related]
7. The 'wildtype' conformation of p53: epitope mapping using hybrid proteins.
Wang PL; Sait F; Winter G
Oncogene; 2001 Apr; 20(18):2318-24. PubMed ID: 11402327
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies.
Menz B; Sester M; Koebernick K; Schmid R; Burgert HG
Mol Immunol; 2008 Nov; 46(1):16-26. PubMed ID: 18692902
[TBL] [Abstract][Full Text] [Related]
9. Differences in epitope accessibility of p53 monoclonal antibodies suggest at least three conformations or states of protein binding of p53 protein in human tumor cell lines.
Danks MK; Whipple DO; McPake CR; Lu D; Harris LC
Cell Death Differ; 1998 Aug; 5(8):678-86. PubMed ID: 10200523
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies.
Bártek J; Bártková J; Lukás J; Stasková Z; Vojtĕsek B; Lane DP
J Pathol; 1993 Jan; 169(1):27-34. PubMed ID: 8433213
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide sequence of the porcine p53 cDNA, and the detection of recombinant porcine p53 expressed in vitro with a variety of anti-p53 antibodies.
Burr PD; Argyle DJ; Reid SW; Nasir L
Oncogene; 1999 Sep; 18(35):5005-9. PubMed ID: 10490836
[TBL] [Abstract][Full Text] [Related]
12. Epitope analysis of the human p53 tumour suppressor protein.
Dolezalová H; Vojtĕsek B; Kovarík J
Folia Biol (Praha); 1997; 43(1):49-51. PubMed ID: 9158951
[TBL] [Abstract][Full Text] [Related]
13. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry.
Bonsing BA; Corver WE; Gorsira MC; van Vliet M; Oud PS; Cornelisse CJ; Fleuren GJ
Cytometry; 1997 May; 28(1):11-24. PubMed ID: 9136751
[TBL] [Abstract][Full Text] [Related]
14. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies.
Kim CL; Umetani A; Matsui T; Ishiguro N; Shinagawa M; Horiuchi M
Virology; 2004 Mar; 320(1):40-51. PubMed ID: 15003861
[TBL] [Abstract][Full Text] [Related]
15. A PAb240+ conformation of wild type p53 binds DNA.
McLure KG; Lee PW
Oncogene; 1996 Sep; 13(6):1297-303. PubMed ID: 8808704
[TBL] [Abstract][Full Text] [Related]
16. Critical residues of epitopes recognized by several anti-p53 monoclonal antibodies correspond to key residues of p53 involved in interactions with the mdm2 protein.
Portefaix JM; Thebault S; Bourgain-Guglielmetti F; Del Rio M; Granier C; Mani JC; Navarro-Teulon I; Nicolas M; Soussi T; Pau B
J Immunol Methods; 2000 Oct; 244(1-2):17-28. PubMed ID: 11033015
[TBL] [Abstract][Full Text] [Related]
17. Restoration of wild-type conformation to full-length and truncated p53 proteins: specific effects of ATP and ADP.
Warnock LJ; Raines SA
Cancer Biol Ther; 2004 Jul; 3(7):634-7. PubMed ID: 15136763
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions.
Stephen CW; Helminen P; Lane DP
J Mol Biol; 1995 Apr; 248(1):58-78. PubMed ID: 7537340
[TBL] [Abstract][Full Text] [Related]
19. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR
Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078
[TBL] [Abstract][Full Text] [Related]
20. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
